Pseudodyssynergia
Pseudodyssynergia is a medical condition characterized by the abnormal functioning of the bladder and urethra during the process of urination. This condition is also known as detrusor-sphincter dyssynergia (DSD), a term that is more commonly used in medical literature.
Symptoms[edit | edit source]
The symptoms of pseudodyssynergia can vary greatly from person to person. Some individuals may experience mild discomfort during urination, while others may have severe pain and difficulty urinating. Common symptoms include:
- Difficulty starting a urine stream
- Feeling of incomplete bladder emptying
- Frequent urination
- Urgency to urinate
- Urinary incontinence
- Urinary tract infections
Causes[edit | edit source]
Pseudodyssynergia is often caused by a disruption in the coordination between the bladder and the urethra. This can occur due to a variety of reasons, including:
- Neurological disorders such as Multiple sclerosis and Spinal cord injury
- Damage to the nerves that control the bladder and urethra
- Certain medications
- Aging
Diagnosis[edit | edit source]
Diagnosis of pseudodyssynergia typically involves a thorough medical history and physical examination, as well as various tests to assess bladder and urethral function. These tests may include:
- Urodynamic testing
- Cystoscopy
- Urinalysis
- Ultrasound of the bladder and kidneys
Treatment[edit | edit source]
Treatment for pseudodyssynergia is aimed at managing symptoms and improving bladder and urethral function. This may involve:
- Medications to relax the bladder and urethra
- Physical therapy to strengthen the pelvic floor muscles
- Biofeedback to improve coordination between the bladder and urethra
- Surgery in severe cases
See also[edit | edit source]
References[edit | edit source]
Pseudodyssynergia Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD